Emesis

16 registered clinical trials studyying Emesis.

Status	Trial	Sponsor	Phase
Completed	The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy NCT04585841	University of Copenhagen	Phase 1
Unknown	Evaluation of Meclizine Orodispersible Tablet Pharmacokinetic in Human Volunteers NCT04564144	Mansoura University	Phase 1 / Phase 2
Completed	MinSafeStart - Decision Aid Tool for Better Treatment of Nausea and Vomiting During Pregnancy NCT04719286	Hedvig Marie Egeland Nordeng	N/A
Unknown	Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vo NCT03478605	Blokhin's Russian Cancer Research Center	Phase 2
Completed	Promoting Safe Medication Use in Pregnancy in the Era of Real-World Data - The SafeStart Study NCT04182750	Hedvig Marie Egeland Nordeng	N/A
Completed	DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence NCT02980289	Signe Harder	—
Completed	Post- Surgery Recovery: Nerve Blocks w/ Sedation vs. Nerve Block w/ Either Sedation/Gen. Anesthesia NCT02602080	Hospital for Special Surgery, New York	—
Unknown	Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy NCT02407600	Ajeet Gajra	Phase 2
Unknown	Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients. NCT01913990	Ottawa Hospital Research Institute	Phase 4
Completed	High Protein Intake to Decrease Emesis and Promote Patient Satisfaction in Labor NCT01414478	University of Pittsburgh	N/A
Completed	Different Feeding Methods After Pyloromyotomy NCT01509417	Children's Mercy Hospital Kansas City	N/A
Terminated	Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis NCT01148264	Karin Jordan	Phase 2
Completed	Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy NCT01046240	Clinica Universidad de Navarra, Universidad de Navarra	Phase 1 / Phase 2
Terminated	Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cance NCT00869973	S. Maria Hospital, Terni	Phase 3
Terminated	Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis NCT00869310	S. Maria Hospital, Terni	Phase 3
Completed	Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy NCT00152867	University Health Network, Toronto	Phase 3